Review By | Apply | May Apply | Neutral | Avoid | Not Rated |
---|---|---|---|---|---|
Count | 0 | 0 | 0 | 0 | 0 |
% | 0 | 0 | 0 | 0 | 0 |
The Captial Market (CapitalMarket.com) rating for Entero Healthcare Solutions IPO is 38. Their analysis recommends Do Not Subscribe for the IPO.
Reviewer | Rating Score | Rating |
---|---|---|
Capital Market | 38 | Do Not Subscribe |
[Dilip Davda] The company is one of the leading and fastest growing healthcare product distributor in India. EHSL marked losses for FY21 to FY23 and turned the corner for H1 of FY24. Based on annualized FY24 earnings, the issue appears aggressively priced, discounting all near term positives. Well-informed/risk seeker/cash surplus investors may park funds for the long term reward as it holds prospects going forward. Read detail review...
Entero Healthcare Solutions Limited peer comparison with similar listed entities. (As on March 31, 2023)
Company Name | EPS (Basic) | EPS (Diluted) | NAV (per share) (Rs) | P/E (x) | RoNW (%) | P/BV Ratio | Financial statements |
---|---|---|---|---|---|---|---|
Entero Healthcare Solutions Limited | -3.43 | -3.43 | 174.21 | -1.86 | Consolidated | ||
Medplus Health Services Limited | 4.17 | 4.17 | 124.93 | 177.21 | 3.36 | 5.91 | Consolidated |
Notes:
(a) Financial information for Company is derived from the Restated Consolidated Financial Information for the year ended March 31, 2023
For listed peers:
(b) All the financial information for listed industry peer mentioned above is on a consolidated basis and is sourced from the annual reports/annual results as available of the respective company for the year ended March 31, 2023 submitted to stock exchanges.
(c) P/E Ratio has been computed based on the closing market price of equity shares on NSE on August 28, 2023, divided by the Diluted EPS.
(d) Return on Net Worth (RoNW) (%) = Net Profit / (Loss) after tax/ Net worth (Total Equity) at the end of the year.
(e)Net asset value per share (in ₹) represents net asset value per equity share post conversion. It is calculated as net worth as of the end of the relevant year divided by the number of equity share post conversion outstanding at the end of the respective year The Company shall undertake conversion of the outstanding CCPS into Equity Shares prior to filing of the Red Herring Prospectus. The conversion of such CCPS into Equity Shares shall depend on certain assumptions and variable factors based on the formula prescribed in the Shareholder's Agreement. The actual number of Equity Shares which may arise out of the conversion of CCPS may vary.
Entero Healthcare Solutions IPO Reviews, analysis and views by popular members. Read Entero Healthcare Solutions Ltd. IPO reviews by retail investors to find recommended ipo to buy.
Review By | Apply | May Apply | Neutral | Avoid |
---|---|---|---|---|
Count | 0 | 0 | 0 | 0 |
% | 0.00 | 0.00 | 0.00 | 0.00 |
Member | Review |
---|---|
No recommendation found. Be the first to post the recommendation. |
Note:
Useful Articles